相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma
Sven H. Loosen et al.
PLOS ONE (2020)
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis - epidemiology, risk factors, clinical implications and treatment
Wojciech Stras et al.
CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)
Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review
Kyoko Oura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization
Hamdy E. A. Ali et al.
CLINICAL BIOCHEMISTRY (2019)
Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients
Lobna Mourad et al.
CANCER BIOLOGY & THERAPY (2018)
No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis
Andrew M. Moon et al.
GASTROENTEROLOGY (2018)
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Kristina Tzartzeva et al.
GASTROENTEROLOGY (2018)
The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity
Florian Schueller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients
Noha Mohamed Hosni Shaheen et al.
VIRUS RESEARCH (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis
Sanchari Roy et al.
GASTROENTEROLOGY (2018)
The PPAR alpha-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions
J. Christopher Corton et al.
ARCHIVES OF TOXICOLOGY (2018)
Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
Ying Zhang et al.
MEDICINE (2017)
Role of circulating microRNAs in liver diseases
Sven H. Loosen et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma
Fan Chen et al.
CANCER BIOMARKERS (2017)
A network-biology perspective of microRNA function and dysfunction in cancer
Cameron P. Bracken et al.
NATURE REVIEWS GENETICS (2016)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system
Lidia Daimiel-Ruiz et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma
Lin Chen et al.
TUMOR BIOLOGY (2015)
Biomarkers for the early diagnosis of hepatocellular carcinoma
Nobuhiro Tsuchiya et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival
Tao Li et al.
ONCOLOGY REPORTS (2014)
MicroRNAs 103 and 107 regulate insulin sensitivity
Mirko Trajkovski et al.
NATURE (2011)
Peroxisome proliferator-activated receptor-α and liver cancer:: where do we stand?
JM Peters et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)